Singapore - English - HSA (Health Sciences Authority)

servier (s) pte ltd - amlodipine besilate 13.87 mg eqv amlodipine; perindopril 3.395 mg eqv perindopril arginine - tablet - 10mg - amlodipine besilate 13.87 mg eqv amlodipine 10mg; perindopril 3.395 mg eqv perindopril arginine 5 mg

Singapore - English - HSA (Health Sciences Authority)

servier (s) pte ltd - amlodipine besilate 6.935 mg eqv amlodipine; perindopril 3.395 mg eqv perindopril arginine - tablet - 5mg - amlodipine besilate 6.935 mg eqv amlodipine 5mg; perindopril 3.395 mg eqv perindopril arginine 5 mg

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - enalapril maleate - tablet - enalapril maleate 20 mg - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - enalapril maleate - tablet - enalapril maleate 5 mg - agents acting on the renin-angiotensin system

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - ramipril - oral capsule - 1.25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - ramipril - oral capsule - 5mg

Israel - English - Ministry of Health

sanofi israel ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - suspension for injection - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:- active immunisation of adults, including pregnant women, and children from 6 months of age and older- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women.the use of vaxigrip tetra should be based on official recommendations.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tigecycline - powder for solution for infusion - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), bacteroides fragilis, bacteroides thetaiotaomicron, bacteroides uniformis, bacteroides vulgatus, clostridium perfringens, and peptostreptococcus micros.community-acquired bacterial pneumonia:community-acquired bacterial pneumonia caused by streptococcus pneumoniae (penicillin susceptible isolates), including cases with concurrent bacteremia, haemophilus influenzae (beta-lactamase negative isolates), and legionella pneumophila.

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - amlodipine besylate 13.87mg (corresponds to amlodipine base); valsartan - tablet, film coated - 10.0mg - amlodipine besylate 13.87mg (corresponds to amlodipine base) 10.0mg; valsartan 160.0mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - amlodipine besylate 6.94mg (corresponds to amlodipine base); valsartan - tablet, film coated - 5mg - amlodipine besylate 6.94mg (corresponds to amlodipine base) 5mg; valsartan 160.0mg